| A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 O Sharma, AA Sultan, H Ding, CR Triggle Frontiers in immunology 11, 585354, 2020 | 637 | 2020 |
| The endothelium: influencing vascular smooth muscle in many ways CR Triggle, SM Samuel, S Ravishankar, I Marei, G Arunachalam, H Ding Canadian journal of physiology and pharmacology 90 (6), 713-738, 2012 | 310 | 2012 |
| Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, ... Circulation 131 (21), 1861-1871, 2015 | 286 | 2015 |
| FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting Q Liang, L Zhong, J Zhang, Y Wang, SR Bornstein, CR Triggle, H Ding, ... Diabetes 63 (12), 4064-4075, 2014 | 286 | 2014 |
| Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor (s) JJ McGuire, H Ding, CR Triggle Canadian journal of physiology and pharmacology 79 (6), 443-470, 2001 | 238 | 2001 |
| Metformin modulates hyperglycaemia‐induced endothelial senescence and apoptosis through SIRT1 G Arunachalam, SM Samuel, I Marei, H Ding, CR Triggle British journal of pharmacology 171 (2), 523-535, 2014 | 223 | 2014 |
| A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic CR Triggle, D Bansal, H Ding, MM Islam, EABA Farag, HA Hadi, ... Frontiers in immunology 12, 631139, 2021 | 204 | 2021 |
| Metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium M Kinaan, H Ding, CR Triggle Medical principles and practice 24 (5), 401-415, 2015 | 193 | 2015 |
| Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress? B Basha, SM Samuel, CR Triggle, H Ding Experimental diabetes research 2012, 2012 | 188 | 2012 |
| Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium H Ding, CR Triggle Vascular Health and Risk Management 1 (1), 55-71, 2005 | 157 | 2005 |
| Acetylcholine‐induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase GJ Waldron, H Ding, F Lovren, P Kubes, CR Triggle British Journal of Pharmacology 128 (3), 653-658, 1999 | 157 | 1999 |
| The endothelium in health and disease-a target for therapeutic intervention CR Triggle, M Hollenberg, TJ Anderson, H Ding, YF Jiang, L Ceroni, ... Journal of Smooth Muscle Research 39 (6), 249-267, 2003 | 156 | 2003 |
| A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan I Mohammed, MD Hollenberg, H Ding, CR Triggle Frontiers in endocrinology 12, 718942, 2021 | 150 | 2021 |
| Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, ... Cell reports 26 (10), 2738-2752. e4, 2019 | 149 | 2019 |
| Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells H Ding, M Aljofan, CR Triggle Journal of cellular physiology 212 (3), 682-689, 2007 | 140 | 2007 |
| Endothelial dysfunction in diabetes: multiple targets for treatment H Ding, CR Triggle Pflügers Archiv-European Journal of Physiology 459 (6), 977-994, 2010 | 135 | 2010 |
| Endothelial dysfunction in the streptozotocin‐induced diabetic apoE‐deficient mouse H Ding, M Hashem, WB Wiehler, W Lau, J Martin, J Reid, C Triggle British journal of pharmacology 146 (8), 1110-1118, 2005 | 131 | 2005 |
| Metformin: Is it a drug for all reasons and diseases? CR Triggle, I Mohammed, K Bshesh, I Marei, K Ye, H Ding, R MacDonald, ... Metabolism 133, 155223, 2022 | 130 | 2022 |
| A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS CR Triggle, H Ding Journal of the American Society of Hypertension 4 (3), 102-115, 2010 | 122 | 2010 |
| Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress M El-Daly, VKP Venu, M Saifeddine, K Mihara, S Kang, PWM Fedak, ... Vascular pharmacology 109, 56-71, 2018 | 111 | 2018 |
